Changes in platelet activity are frequently observed in migraine sufferers, particularly during the attack. Therefore, much effort has gone into trying to beneficially regulate platelet activity in migraine sufferers. The recent success of sumatriptan in the relief of migraine symptoms has led to studies addressing the effect of this drug on platelet activity. Tozzi-Ciancarelli et al. studied whether sumatriptan modifies platelet activity either directly or indirectly. Although sumatriptan in concentrations of 1-100 μM had no direct effect on platelet activity, platelets pretreated with 100 μM sumatriptan became less responsive to the stimulatory effects of serotonin and ADP. These findings raise the possibility that sumatriptan, in addition to its known central nervous system effects, may also modify platelet activity. In a condition such as migraine, one generally wishes to avoid the use of drugs that promote platelet activity with its attendant risk of thromboembolism. Whilst the observation that sumatriptan may actually inhibit platelet activity is reassuring, the importance of these findings for the mechanism of action of sumatriptan needs investigation.
International comparisons in migraine epidemiology WALTER F STEWART

RICHARD B LIPTON
In the study by Haimanot and coworkers (1), the one-year period prevalence of migraine in Ethiopia was 3%, considerably lower than estimates from comparable studies in primarily Caucasian populations in the United States and Western Europe (2) (3) (4) (5) . International variation in migraine prevalence could result from methodologic differences among studies, cultural differences in symptom reporting, variation in environmental risk factors, or race-related differences in genetic susceptibility to migraine (3) (4) (5) (6) . The available evidence supports a possible role for both environmental and genetic risk factors.
The development of International Headache Society (IHS) criteria for migraine has facilitated international comparisons in epidemiologic studies by providing explicit and consistent diagnostic criteria (7) . Haimanot et al. (1) applied the INS criteria in their door-to-door survey. Though the overall prevalence of migraine is dramatically lower in Ethiopia, the shape of the age-specific prevalence profile in this study resembles the previous reports in primarily Caucasian samples (2) (3) (4) (5) ; prevalence rises in young adults, peaks in early mid-life and falls thereafter. The gender ratio of 1:2.8 with a clear female preponderance is virtually identical to the findings in Caucasian samples (2) (3) (4) (5) . If environmental risk factors account for the differences in migraine prevalence across studies, these risk factors would have to have a uniform effect in the age and gender groups included in the study. Differences in genetic susceptibility might be expected to produce consistent effects across age and gender groups yielding the patterns reported by Haimanot and colleagues (1).
These findings are consistent with a recent study conducted in Baltimore County Maryland (6) . In that study, migraine prevalence was substantially lower in African Americans than in Caucasian Americans after controlling for age and gender. If environmental or cultural factors accounted for racial differences, we would expect these differences to dramatically decline when the race groups shared a common environment; a genetic model would predict that differences should persist. The Baltimore County findings therefore suggest that genetic mechanism may help account for racial differences in migraine prevalence. Though lower than the estimates in Caucasians, the prevalence of migraine in African Americans was higher than in the Ethiopian sample.
As the worldwide database on migraine epidemiology continues to expand, international comparisons in migraine epidemiology may be fruitful. Comparative studies have yielded important insights into risk factors for other diseases. For example, the role of cholesterol as a risk factor for myocardial infarction was discovered, in part, because of international differences in the prevalence of heart disease. Application of this strategy to migraine requires that we search for variation in migraine prevalence across various definable groups and then identify the genetic or environmental factors which account for the variation.
Power spectrum analysis of heart rate fluctuation in cluster headache
ARIEH KURITZKY
There is increasing evidence for brain control over cardiac rhythm and blood supply. Moreover, in the insular cortex and other cortical areas, there are arrhythmogenic representations which could be modulated by specific lesions as well as by neuroactive peptides such as neuropeptide Y or by opioids. As a result, the heart, as the target organ, could be used as a probe to study the function of the different segments of the autonomic nervous system.
In this issue of Cephalalgia, De Marinis and her colleagues have studied power spectrum analysis of heart rate fluctuations using a 24-h Holter ECG monitoring enabling them to evaluate the sympathetic vs parasympathetic function in patients with cluster headache (CH) during the cluster period, between and during the cluster attack. They measured the low frequency (LF) component, which represents sympathetic instability, as well as the high frequency (HF) component, which is of pure vagal origin and represents the parasympathetic arm. The data show that the results obtained are very different from those in migraine. Unlike migraine, where a marked sympathetic enhancement was demonstrated during the interheadache phase, no abnormality was found in the CH group. Moreover, a head-up tilt test was still normal in CH, whereas Zigelman et al.
(1) showed a trifold LF power increase in migraine. Unfortunately, we do not have good data regarding power spectrum changes during a migraine attack. This is an important study that contributes to our understanding of the autonomic balance in headache. It clearly shows that the basic autonomic activity is very different in CH compared to migraine. This study demonstrates for the first time parasympathetic enhancement during the cluster attack. This may direct us to further investigate the role of the parasympathetic system in CH and possibly develop a treatment aimed to stabilize this system.
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Response measures in the acute treatment of migraine MICHAEL VON KORFF
In this issue, Skovlund and Flaten report useful and innovative analyses comparing the statistical power of a four-point verbal rating scale and a 100 mm visual analogue pain rating scale for assessing therapeutic efficacy in a randomized trial of acute migraine treatment. They conclude that the two measures yield essentially equivalent power. Advantages of a four-point verbal rating scale are that each level on the scale has a readily interpretable clinical meaning (no pain, mild, moderate or severe pain), and that it is easily administered and scored. It is interesting that these advantages are gained without sacrificing ability to detect a treatment effect relative to a pain rating permitting finer differentiation of pain levels, the visual analogue scale. If this result can be replicated using samples with a smaller difference in outcomes between the intervention and control groups, it would suggest that one potential disadvantage of the verbal descriptor scale as an outcome measure in randomized trials may not be of practical significance.
In general, there is a need for methodologic research to develop and assess improved methods of measuring outcomes in clinical trials of headache treatments. The paper by Skovlund and Flaten concerns a methodologic issue in assessing the short-term effects of acute treatment. Increased attention also needs to be paid to methods of assessing medium to long-term pain and functional outcomes. Important methodologic questions that have not been fully resolved are the relative strengths and limitations of diary versus patient recall for measuring pain and functioning over a defined time interval, the duration of follow-up needed to adequately characterize long-term outcomes, the optimal frequency and timing of assessments during medium to long-term follow-up, and the reliability and validity of alternative methods of assessing headache-related disability in work and family role performance. Methodologic research on these questions would improve the scientific bases for evaluating the long-term effects of migraine treatment.
Stress and tension-type headache HARTMUT GÖBEL
Retrospective studies list that stress, strain, fear and other emotional influences are the most important trigger factors for tension-type headache. Apart from their potential triggering effect, these factors are also capable of sustaining and aggravating existing headaches. However, the global assumption that stress can cause headache includes a number of difficulties. Retrospective inquiries do not always make it very clear whether stress really triggers tension-type headache. Retrospectively collecting information about stress factors leads to memory affecting the answers. For example, only the events during the latest headache episode may be reported. Furthermore, answers to retrospective inquiries may be coloured in view of assumed social acceptance. General prejudices about the triggering of headache may also find their way into the answers, e.g. information from the press holding that stress causes headache.
Analysing the connection between experimental stress factors and headache is of only limited value for the assessment of everyday situations. Experimental stress situations such as mental arithmetic or the presentation of pictures imposing a strain have to be marked as one-dimensional as far as their constellation of psychological stimuli is concerned. Many stress characteristics, such as the individual evaluation or the situational character of everyday stress, cannot be represented adequately.
For the first time, the study by Clark et al. in this issue analyses the connection between tension-type headache and stress, temporalis muscle EMG and physical activity prospectively over a period of 6 days. While temporalis muscle EMG and physical activity are not cross-correlated to the headache, this study shows a significant positive correlation between headache and stress. Increase in stress may be an hour or more before the increase of pain. The comparatively small number given for the coefficient of correlation proves, on the other hand, that stress is only one of many factors to explain the variability of headache.
The study is a valuable reference for information about the importance of prophylactic measures for the prevention of tension-type headache. Thus, according to the results of Clark et al., therapeutic interventions by physical activity and changes of the muscle tonus may have only little influence on the headache. Stress management, on the other hand, may have at least a certain effect on the course of the headache attack. The results of the study are yet another example of the fact that reducing stress by the application of relaxation treatment and particularly by planning a smooth and regular daily routine without peak stress situations is an important stepping stone in non-medicinal headache therapy.
Migraine triggers ANNE MACGREGOR
Clinicians differ on the frequency with which they can elicit trigger factors from patients with migraine-some quote a high proportion and others are unable to help patients identify any trigger factors at all. Subjective information is not always reliable, however, and there is no doubt that when patients are asked to keep an objective record a pattern frequently emerges of attacks in relation to missed meals, exercise, menstruation, etc. The paper by Turner et al. cites the results of a telephone questionnaire in which 901 people were surveyed to assess the diagnosis of migraine in relation to specific triggers. The authors suggest that those who had Raynaud's phenomenon or menstrual migraine were more sensitive to certain environmental stimuli. Clearly there are limitations to this study because a telephone survey does not provide an accurate diagnosis, and subjective off-the-cuff responses are not always reliable. Further, other variables are not taken into consideration; patients with more frequent attacks may suspect more triggers, and frequency of attacks is not accounted. Nevertheless, these results do provide useful preliminary information on which a follow-up study could be based. Personal interviews to establish the diagnosis followed by the use of a diary to chart frequency of attacks and presence or absence of trigger factors would refute or confirm the authors' suspicions.
